{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:29:54Z","timestamp":1793845794700,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.aprim.2021.102208","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T13:10:41Z","timestamp":1637068241000},"page":"102208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Migraine review for general practice"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-7098","authenticated-orcid":false,"given":"Antonio L.","family":"Aguilar-Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Membrilla MD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-6269","authenticated-orcid":false,"given":"Javier","family":"Diaz-de-Teran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2021.102208_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","article-title":"Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019","volume":"21","author":"Steiner","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.aprim.2021.102208_bib0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.aprim.2021.102208_bib0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ncl.2019.07.008","article-title":"An update: pathophysiology of migraine","volume":"37","author":"Goadsby","year":"2019","journal-title":"Neurol Clin [Internet]"},{"key":"10.1016\/j.aprim.2021.102208_bib0180","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","article-title":"Migraine","volume":"391","author":"Dodick","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2021.102208_bib0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/head.12572","article-title":"The premonitory phase of migraine \u2013 what can we learn from it?","volume":"55","author":"Maniyar","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.aprim.2021.102208_bib0190","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/head.13101","article-title":"Aura and other neurologic dysfunction in or with migraine","volume":"57","author":"Kissoon","year":"2017","journal-title":"Headache"},{"issue":"4-Headache","key":"10.1016\/j.aprim.2021.102208_bib0195","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1212\/CON.0000000000000626","article-title":"The migraine postdrome","volume":"24","author":"Bose","year":"2018","journal-title":"Contin Lifelong Learn Neurol"},{"key":"10.1016\/j.aprim.2021.102208_bib0200","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.wnl.0000325565.63526.d2","article-title":"Clinical course in migraine: conceptualizing migraine transformation","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.aprim.2021.102208_bib0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic migraine: risk factors, mechanisms and treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat Rev Neurol [Internet]"},{"key":"10.1016\/j.aprim.2021.102208_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/head.13720","article-title":"Neuroimaging for migraine: the American Headache Society systematic review and evidence-based guideline","volume":"60","author":"Evans","year":"2020","journal-title":"Headache"},{"key":"10.1016\/j.aprim.2021.102208_bib0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine","volume":"84","author":"Lipton","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.aprim.2021.102208_bib0220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-2982.2007.01303.x","article-title":"The triggers or precipitants of the acute migraine attack","volume":"27","author":"Kelman","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.aprim.2021.102208_bib0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s10194-015-0516-6","article-title":"Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"16","author":"Gaul","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.aprim.2021.102208_bib0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.aprim.2021.102208_bib0235","article-title":"Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults","volume":"2013","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2021.102208_bib0240","series-title":"Manual de Pr\u00e1ctica cl\u00ednica en cefaleas: Recomendaciones diagn\u00f3stico-terape\u00faticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda 2020","author":"Santos-Lasaosa","year":"2020"},{"key":"10.1016\/j.aprim.2021.102208_bib0245","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2165\/11537990-000000000-00000","article-title":"Triptans for the management of migraine","volume":"70","author":"Johnston","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.aprim.2021.102208_bib0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1526-4610.2004.04078.x","article-title":"Consensus statement: cardiovascular safety profile of triptans (5-HT 1B\/1D agonists) in the acute treatment of migraine","volume":"44","author":"Dodick","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.aprim.2021.102208_bib0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1474-7766.2004.03-205.x","article-title":"Acute migraine: which triptan?","volume":"4","author":"Gladstone","year":"2004","journal-title":"Pract Neurol"},{"issue":"S4","key":"10.1016\/j.aprim.2021.102208_bib0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/head.12601","article-title":"Triptans in the acute treatment of migraine: a systematic review and network meta-analysis","volume":"55","author":"Cameron","year":"2015","journal-title":"Headache"},{"issue":"Suppl. E1","key":"10.1016\/j.aprim.2021.102208_bib0265","article-title":"Migraine headache: diagnosis and current and emerging preventive treatments","volume":"20","author":"Lipton","year":"2018","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.aprim.2021.102208_bib0270","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/CON.0000000000000199","article-title":"Preventive migraine treatment","volume":"21","author":"Silberstein","year":"2015","journal-title":"Contin Lifelong Learn Neurol"},{"key":"10.1016\/j.aprim.2021.102208_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.e5765","article-title":"Diagnosis and management of headaches in young people and adults: Summary of NICE guidance","volume":"345","author":"Carville","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2021.102208_bib0280","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.aprim.2021.102208_bib0285","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010611","article-title":"Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2021.102208_bib0290","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.aprim.2021.102208_bib0295","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-019-0823-8","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the preventative treatment of episodic migraine in adults","volume":"23","author":"Dorosch","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.aprim.2021.102208_bib0300","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/j.pain.0000000000001456","article-title":"Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis","volume":"160","author":"Stubberud","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.aprim.2021.102208_bib0305","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.aprim.2021.102208_bib0310","first-page":"1","article-title":"Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine \u2013 an updated systematic review and meta-analysis","volume":"201","author":"Deng","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.aprim.2021.102208_bib0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nrl.2016.04.017","article-title":"Consensus recommendations for anaesthetic peripheral nerve block","volume":"32","author":"Santos Lasaosa","year":"2017","journal-title":"Neurologia"},{"key":"10.1016\/j.aprim.2021.102208_bib0320","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nrl.2017.08.001","article-title":"How and when to refer patients diagnosed with primary headache and craniofacial neuralgia in the Emergency Department or Primary Care: recommendations of the Spanish Society of Neurology's Headache Study Group","volume":"35","author":"Gago-Veiga","year":"2020","journal-title":"Neurologia"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:01:12Z","timestamp":1759323672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656721002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0212656721002420"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102208","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migraine review for general practice","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102208"}}